Allarity Therapeutics, Inc. Other Additional Capital
Allarity Therapeutics, Inc. (ALLR) had Other Additional Capital of $150.00 thousand as of 2024-05-01, per its 10-Q filed 2024-08-05.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:OtherAdditionalCapital · last filed 2024-08-05
- 2024-05-01: Other Additional Capital $150.00K.
- 2024-03-31: Other Additional Capital $90.52M.
- 2022-06-30: Other Additional Capital $1.51M.
- 2022-03-31: Other Additional Capital $134.00K.
| Period end | Other Additional Capital |
|---|---|
| 2024-05-01 | $150.00K 10-Q · filed 2024-08-05 |
| 2024-03-31 | $90.52M 10-Q · filed 2024-05-14 |
| 2022-06-30 | $1.51M 10-Q · filed 2022-10-07 |
| 2022-03-31 | $134.00K 10-Q · filed 2022-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |